Fisher & Paykel Healthcare announces 2022 Investor Day

GENERAL

Thu, Apr 14 2022 10:50 am

News Release
STOCK EXCHANGE LISTINGS: NEW ZEALAND (FPH), AUSTRALIA (FPH)
Fisher & Paykel Healthcare announces 2022 Investor Day
Auckland, New Zealand, 14 April 2022
Fisher & Paykel Healthcare Corporation Limited today announced it will hold an Investor Day on Thursday, 26 May 2022 following its financial results announcement on 25 May.

The Investor Day will provide investors with the opportunity to meet senior management and hear presentations on our range of new products, their clinical benefits and our growth opportunities.

Event: Fisher & Paykel Healthcare 2022 Investor Day
Venue: Daniell Building, Fisher & Paykel Healthcare Limited, 15 Maurice Paykel Place, East Tamaki, Auckland 2013
Programme: 10am – 2.30pm (with an optional site tour from 2.30pm onwards)

The Investor Day will be presented in person, with a webcast available for those wishing to join remotely. Investors and analysts will be able to ask questions in the room and/or online. While every endeavour will be made to answer all questions that are submitted, this may not be possible due to time constraints. Please note we may move this session to online-only in the event of increased COVID-19 protection measures.

Please register at the following site, with an indication of whether you will attend in person or online: www.fphcare.com/investor-day/. Details on how to access the webcast will be provided to you prior to the event.

Registrations close Friday 20 May 2022.

About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in over 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.
Ends

Media & Investor Contacts:

Karen Knott
GM Corporate Communications
[email protected]
+64 (0) 21 713 911

Hayden Brown
Investor Relations Manager
[email protected]
+64 (0) 27 807 8073

Authorised by Fisher & Paykel Healthcare Corporation Limited’s Company Secretary.